Technology Evaluation | SAFE SUGAR™, OMNIPHYX™, BSS™ & Lathell Health Innovation Platforms

Platform Evaluation Overview

Lathell Nutraceuticals is building a portfolio of next-generation health innovation platforms designed for real-world scale. These technologies span medical-grade ingredient innovation, physiological intelligence systems, and advanced monitoring concepts intended to address major global challenges in metabolic health, chronic disease burden, nutrition systems, and health analytics.

Organizations exploring strategic collaboration may include ingredient manufacturers, food and beverage companies, research institutions, hospitals, government health bodies, advanced analytics groups, universities, industrial partners, and institutions seeking scalable solutions with long-term global relevance.

Evaluation discussions may cover technical fit, application alignment, research collaboration, manufacturing pathways, licensing structures, pilot frameworks, institutional deployment, and broader strategic alignment with public health, commercial innovation, or research objectives.

What this page covers

Platforms available for review: SAFE SUGAR™, OMNIPHYX™, and BSS™.
Evaluation pathways: licensing, research collaboration, manufacturing, institutional deployment, and platform integration.
Who this is for: industry partners, institutions, investors, universities, government programs, and advanced innovation teams.
How to begin: direct contact with Lathell Nutraceuticals for structured evaluation discussions.

Lathell Technology Platforms Available for Evaluation

The Lathell platform ecosystem is designed to support multiple engagement models depending on the organization, application area, and strategic objective. Each platform addresses a different layer of innovation within nutrition, metabolic health, physiological intelligence, and advanced monitoring environments.

Ingredient Platform

SAFE SUGAR™ Very-Low-Glycemic Ingredient Platform

SAFE SUGAR™ is a medical-grade, very-low-glycemic sweetener ingredient platform designed to support improved metabolic positioning relative to conventional sugar systems while maintaining practical relevance for manufacturing, formulation, institutional nutrition, and product reformulation environments.

The platform is positioned for organizations seeking alternatives suited to modern metabolic health realities, including diabetes-related nutrition pressures, sugar reduction strategies, hospital nutrition systems, public health programs, and large-scale food reformulation objectives. SAFE SUGAR™ is intended to support a higher-standard ingredient pathway for organizations looking beyond conventional sweetener solutions.

Evaluation may include ingredient-fit assessment, manufacturing compatibility discussions, use-case alignment, institutional or industrial deployment models, licensing exploration, and broader strategic discussions around population health impact and food-system innovation.

Potential application areas

Food and beverage reformulation strategies
Medical nutrition and institutional dietary systems
Hospital and healthcare procurement pathways
Government health and diabetes-related initiatives
Functional food and nutrition innovation platforms
Global licensing and manufacturing partnerships

Evaluation discussion points

Ingredient technology review and strategic fit
Commercial and institutional application pathways
Partnership structure and licensing opportunities
Manufacturing and supply-chain alignment
Pilot or deployment pathway exploration
Long-term platform relevance in metabolic health

Learn More About SAFE SUGAR™ Global Market Opportunity Licensing Partnerships

Physiological Intelligence Platform

OMNIPHYX™ Physiological Intelligence Platform

OMNIPHYX™ is an advanced physiological intelligence platform designed to support integrated monitoring, interpretation, and analysis environments across health-related systems. The platform is positioned as part of a broader architecture for physiological awareness, system-level analytics, and advanced monitoring applications connected to metabolic and biological state evaluation.

The OMNIPHYX™ concept is relevant for organizations working in physiological analytics, advanced monitoring systems, research technology environments, wearable integration pathways, and health innovation ecosystems requiring scalable intelligence architecture rather than isolated tools.

Evaluation discussions may address platform integration opportunities, research use alignment, data environment strategy, institutional collaboration, technical architecture interest, and strategic pathways for long-term development or deployment partnerships.

Potential application areas

Advanced physiological analytics platforms
Metabolic and biological monitoring environments
Wearable or integrated sensing ecosystems
Research and institutional analytics systems
Health data interpretation frameworks
Multi-platform physiological intelligence environments

Evaluation discussion points

Strategic relevance to monitoring or analytics initiatives
Research collaboration opportunities
System architecture fit and platform interoperability
Integration with broader physiological intelligence programs
Institutional or technical development alignment
Commercial or pilot pathway exploration

Learn More About OMNIPHYX™ Technology Platforms

Monitoring Concept Platform

BSS™ Bio-Signal Stability Scanner

BSS™ is an advanced physiological monitoring technology concept focused on evaluating biological signal stability, coherence, and monitoring relevance across health-related environments. It is positioned as a next-generation physiological monitoring technology with potential relevance for wearable systems, advanced monitoring ecosystems, signal analysis environments, and innovation programs exploring deeper interpretation of biological state.

The BSS™ concept is intended for organizations interested in physiological monitoring technology, wearable health innovation, research systems, advanced sensing concepts, and signal-centered health analytics. It supports the broader Lathell vision of building meaningful monitoring architectures rather than isolated point solutions.

Evaluation discussions may include concept fit, research collaboration, technology-development alignment, pilot exploration, institutional interest, and strategic pathways for organizations interested in physiological monitoring systems with broader platform potential.

The BSS™ architecture is part of Lathell’s broader physiological intelligence ecosystem and may be relevant to groups seeking new approaches to signal stability interpretation, monitoring resilience, and next-generation biosignal-centered innovation.

Potential application areas

Wearable physiological monitoring systems
Research and innovation environments
Biological signal stability analysis
Advanced monitoring and sensing concepts
Health and wellness technology ecosystems
Integration with broader physiological intelligence platforms

Evaluation discussion points

Platform relevance to physiological monitoring programs
Research or institutional collaboration potential
Alignment with wearable or analytics roadmaps
Development pathway interest and concept validation
Signal analysis and system-level monitoring use cases
Strategic fit within broader innovation initiatives

Learn More About BSS™ Related Physiological Platform

Partnership & Collaboration Opportunities

Lathell Nutraceuticals is open to structured discussions with organizations seeking practical, strategic, and scalable ways to engage with our technologies. The appropriate pathway depends on the platform, the intended use case, and the type of organization involved.

Licensing Opportunities

Organizations interested in applying Lathell technologies within established commercial, manufacturing, or institutional frameworks may explore licensing discussions where appropriate.

Ingredient licensing pathways for food and nutrition applications
Technology use rights tied to defined strategic markets
Regional, institutional, or sector-focused structures
Long-term commercialization alignment discussions

Manufacturing & Industrial Collaboration

Industrial partners may explore pathways related to scalable production, manufacturing support, formulation compatibility, or operational alignment for selected platform applications.

Manufacturing alignment for ingredient-related systems
Pilot and scale-up discussions
Production readiness and industrial pathway exploration
Strategic collaboration for large-scale implementation

Research & Academic Collaboration

Universities, institutes, research centers, and innovation groups may explore collaborative discussions related to platform evaluation, pilot frameworks, validation pathways, and broader research alignment.

University or institutional research pathways
Joint exploration of use cases and platform relevance
Technical collaboration opportunities
Innovation ecosystem partnerships

Institutional & Government Deployment

Government agencies, hospitals, public health bodies, procurement systems, and institutional decision-makers may explore evaluation discussions where platform relevance aligns with health, nutrition, or systems-level innovation goals.

Institutional nutrition and health deployment pathways
Population-health-oriented pilot discussions
Procurement-aligned innovation exploration
Strategic public-sector collaboration potential

Technology Evaluation Process

Evaluation discussions typically follow a structured path so that both sides can determine relevance, alignment, and practical next steps without unnecessary friction.

1

Initial Inquiry

Contact Lathell Nutraceuticals with your area of interest, organization type, and evaluation objective.

2

Preliminary Fit Review

Initial discussion focuses on use case alignment, platform relevance, and potential strategic fit.

3

Technology Discussion

Qualified discussions may expand into deeper technical, commercial, research, or institutional considerations.

4

Partnership Pathway

The most suitable pathway may involve licensing, collaboration, manufacturing, pilot development, or institutional evaluation.

5

Next-Step Planning

If aligned, both parties may proceed toward formal evaluation, structured engagement, or scoped collaboration planning.

Contact for Technology Evaluation

Organizations interested in SAFE SUGAR™, OMNIPHYX™, BSS™, or the broader Lathell technology ecosystem may contact us directly to initiate evaluation, partnership, collaboration, or strategic discussion.

Contact Lathell Sancho

Title Founder — Lathell Nutraceuticals LLC

Email l.sancho@lathellnutraceuticalsllc.com

Phone +1 (702) 413-4481